journal article·2018-04-25Open access

A landscape of nanomedicine innovations in India

Pooja Bhatia, Suhas Vasaikar, Anil Wali

Nanotechnology Reviews· Volume 7· Issue 2

Abstract

Abstract Nanomedicine is one of the emerging technologies and a branch of nanotechnology finding applications in healthcare. Many countries, including India, are pursuing active research programs in nanomedicine to explore novel healthcare solutions to address specific healthcare needs of the society. At present, the government of India, through its various agencies, is funding nanomedicine research in India. It is anticipated that in the next 5 years or so, several nanomedicine-based products shall reach the market. Thereby, it becomes pertinent to evaluate the extent of India’s involvement in activities related to innovation in nanomedicine. However, a comprehensive landscape of nanomedicine innovation in India is currently lacking. This paper attempts to profile the status of research and innovation in the field of nanomedicine in India. The current study evaluates the innovation on the basis of five indicators: financial ecosystem, technology source, research translation, bibliographic data (patents and publications), and regulation. Public-private partnerships and international collaborations are also discussed in the paper. The landscape elucidates current status of nanomedicine in India and may be relevant for policy-related matters.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Biotechnology and Related Fields · HIV/AIDS Impact and Responses · Innovation and Socioeconomic Development

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Foundation for Innovation and Technology Transfer , Indian Institute of Technology Delhi , Haus Khas, New Delhi-110016 , India

Lester and Sue Smith Breast Center, Baylor College of Medicine , Houston, TX 77030 , USA

References (44)

Show source-provided references
1. Singh S, Pandey VK, Tewari RP, Agarwal V. Nanoparticle based drug delivery system: advantages and applications. Indian J. Sci. Technol. 2011, 4, 167–169.
2. Ge, Y, Li, S, Wang, S, Moore, R, Eds., Nanomedicine: Principles and Perspectives, Springer: New York, 2014.10.1007/978-1-4614-2140-5 ↗
3. Nanotechnology healthcare [Webpage on internet]. Available at http://www.biospectrumindia.com/biospecindia/features/219860/nanotechnology-healthcare/page/2#sthash.4b3hTYMv.dpuf. Accessed on 10 March 2016.
4. Healthcare [Webpage on internet]. Available at http://www.ibef.org/download/Healthcare-August-2015.pdf. Accessed on 10 March 2016.
5. Jain NK. Status of nanomedicine research in India. Nanomed. Nanotechnol. Biol Med. 2006, 2, 269–312.10.1016/j.nano.2006.10.092 ↗
6. Kumar A, Desai PN. Overview of nanobiotechnology public R&D system in India. ABDR 2013, 15, 67–79.
7. Kumar A. Nanotechnology development in India: an overview. Research and Information System for Developing Countries 2014, 193, 1–33. Available at http://ris.org.in/images/RIS_images/pdf/DP%20193%20Amit%20Kumar.pdf.
8. Kumar A, Desai PN. Mapping the Indian nanotechnology innovation system. WJSTSD 2014, 11, 53–65.10.1108/WJSTSD-09-2013-0039 ↗
9. Ali A, Sinha K. Emerging scenario of nanobiotechnology development in India. EAR 2014, II, 1707–1727.
10. Ali A, Sinha K. Prospects of nanotechnology development in the health sector in India. IJHSR 2014, 2, 109–125.
11. Ali A, Sinha K. Exploring the opportunities and challenges in nanotechnology innovation in India. JSSPI 2014, 2, 227–251.
12. Bhattacharya S, Shilpa M. Mapping nanotechnology research and innovation in India DESIDOC. J. Lib. Inf. Technol. 2011, 31, 349–358.
13. Anand M. Nanoscience and nanotechnology. In Innovation in India: Combining Economic Growth with Inclusive Development, Ramani, S, Ed., Cambridge University Press: Cambridge, 2014, pp. 211–242. doi: 10.1017/CBO9781139794640.008.10.1017/CBO9781139794640.008 ↗
14. Shefali, Gangwar R, Devi M, Chhabra P, Prasad B. Role of nano science in development of India. In National Conference on ‘Role of Science and Technology Towards Make in India’ held on 5–7 March, 2016 at YMCA University of Science and Technology, Faridabad. Available at: https://www.researchgate.net/publication/301345920. Accessed on 17 April 2017.
15. Ezema IC, Ogbobe PO, Omah AD. Initiatives and strategies for development of nanotechnology in nations: a lesson for Africa and other least developed countries. Nanoscale Res. Lett. 2011, 9, 133.
16. UNESCO. Mapping Research and Innovation in the Republic of Malawi. Lemarchand, GA, Schneegans, S, Eds., GOàSPIN Country Profiles in Science, Technology and Innovation Policy, vol. 3. United Nations Educational, Scientific and Cultural Organization: Paris, 2014. Available at http://unesdoc.unesco.org/images/0022/002288/228807E.pdf.
17. Lhuillery S, Raffo J, Hamdan-Livramento I. Measuring Creativity: Learning from Innovation Measurement. Economic Research Working Paper No. 31. 2016. Available at http://www.wipo.int/edocs/pubdocs/en/wipo_pub_econstat_wp_31.pdf. Accessed on 25 April 2016.
18. Kaplinsky R, Morris M. A Handbook for Value Chain Research. Institute of Development Studies, University of Sussex and School of Development Studies, University of Natal (2001). Available at https://www.ids.ac.uk/ids/global/pdfs/VchNov01.pdf. Accessed on 25 April 2016.
19. Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat. Biotechnol. 2006, 24, 1211–1217.
20. Dube A, Ebrahim N. The nanomedicine landscape of South Africa. Nanotechnol. Rev. 2017, 6, 339–344.
21. Bawa R, Johnson S. Emerging issues in nanomedicine and ethics’. In Nanotechnology and Society: Current and Emerging Ethical Issues, Allhoff, F, Lin, P, Eds., Springer: Dordrecht, 2007, pp. 207–223.
22. National Institute of Health. National Institute of health roadmap for medical research: Nanomedicine.2006: Para 2. Available from: http://nihroadmap.nih.gov/nanomedicine/. Accessed on 25 April 2016.
23. European Science Foundation. [Webpage on Internet]. Nanomedicine-An ESF-European Medical Research Councils forward look report. 2004. Available from: http://www.nanopharmaceuticals.org/files/nanomedicine.pdf. Accessed on 25 April 2016.
24. European Technology Platform on Nanomedicine, Nanotechnology for Health: Vision paper and basis for a strategic research agenda for nanomedicine. EC Publication office. [Webpage on Internet] September 2005. Available from: ftp://ftp.cordis.europa.eu/pub/nanotechnology/docs/nanomedicine_visionpaper.pdf.
25. Jaspers N. International Nanotechnology Policy and Regulation, Case Study: India, The London School of Economics and Political Science and Lee Kuan Yew School of Public Policy. 2010. Available at http://www.lse.ac.uk/ internationalRelations/centresandunits/regulatingnanotechnologies/nanopdfs/ EuropeanUnion2010.pdf.
26. Bhoop BS, Lohan S, Katare OP. Nanomedicine in India: retrospect to prospects [Webpage on Internet] 2014. Available at http://www.pharmabiz.com/ArticleDetails.aspx?aid=81281&sid=21. Accessed on 25 April 2016.
27. Srivastava N, Chowdhury N. Regulation of health related nano applications in India: Exploring the limitations of the current regulatory design. SSRN 2008, 37, 1–2.10.2139/ssrn.1105685 ↗
28. Vivekanandan J. Nano applications, mega challenges: the case of the health sector in India. Stud. Ethics Law Technol. 2009, 3, Article 3.
29. Ratinho T, Harms R, Walsh S. Structuring the technology entrepreneurship publication landscape: making sense out of chaos. Technol. Forecast. Soc. Change. 2015,100, 168–175.
30. Nanotechnology Research Innovation and Incubation Centre [Webpage on Internet]. Available at http://www.nstedb.com/institutional/tbi-center.htm. Accessed on 18 April 2017.
31. Nano Park and Nano Incubation center [Webpage on Internet]. Available at https://www.biospectrumindia.com/news/18/6076/7th-annual-bangalore-india-nano-inaugurated-html. Accessed on 18 April 2017.
32. Nanotechnology Business Incubator [Webpage on Internet]. Accessed 18 April 2017. Available at http://www.dst.gov.in/sites/default/files/annual-report-2012-13_0.pdf.
33. Pal D, Sahu CK, Haldar A. Bhasma: the ancient Indian nanomedicine. J. Adv. Pharm. Technol. Res. 2014, 5, 4–12.
34. Anand M, Srivastava N, Sarma S. Policy and ethical concerns in nanotechnology safety: case of Indian health sector. J. Biomed. Nanotechnol. 2011, 7, 34–35.
35. Sarma SD. How resilient is India to nanotechnology risks? Examining current developments, capacities and an approach for effective risk governance and regulation. EJLT 2011, 2.
36. Chowdhury N. Regulatory supervision of emerging technologies: a case for nanotechnology in India. Econ. Polit. Wkly. 2006, 41, 4730–4733.
37. Beumer K, Bhattacharya S. Emerging technologies in India: developments, debates and silences about nanotechnology. Sci. Public Policy 2013, 40, 628–643.10.1093/scipol/sct016 ↗
38. Ghosh A, Krishnan Y. At a long awaited turning point. Nat. Nanotechnol. 2014, 9, 491–494.
39. Press Information Bureau. [Webpage on internet] “Continuation of the Mission on Nano Science and Technology in the 12th Plan Period”. Available at http://pib.nic.in/newsite/PrintRelease.aspx?relid=103969. Accessed on 18 April 2017.
40. Draft guidelines and best practices for safe handling of nanomaterials. [Webpage on internet]. Available from http://nanomission.gov.in/. Accessed on 18 April 2017.
41. Bhattacharya S. Governance and regulation in an emerging technology: nanotechnology as a case study. In India Science and Technology, Banerjee, P, Bhattacharya, S, Kumar, V, Mandal, K, Mehra, K, Pohit, S, Raina, RS, Suman, S, Eds., Cambridge University Press: New Delhi, 2015, pp. 215–218.
42. The Energy and Resources Institute (TERI). Regulatory Challenges posed by Nanotechnology Developments in India. TERI project: capability, Governance, and Nanotechnology Developments – a focus on India New Delhi: The Energy and Resources Institute. [Project Report No. 2006ST21: D6], 2009.
43. Purushotham H, Karanam M. Knowledge management and regulatory issues – key for sustainable development of nanoscience and technology in India. In International Conference on Nanoscience, Engineering and Technology (ICONSET), November 28–30, 2011.10.1109/ICONSET.2011.6167915 ↗
44. Bhatia P, Chugh A. A multilevel governance framework for regulation of nanomedicine in India. Nanotechnol. Rev. 2016, 6, 373–382.